Baker Bros. Advisors’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Baker Bros. Advisors’s Portfolio BLCM Stock Details BLCM Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-249,123	Closed	-$82.2K	–	111
2023 Q1	$82.2K	Hold	249,123	–	–	﹤0.01%	105
2022 Q4	$179K	Hold	249,123	–	–	﹤0.01%	111
2022 Q3	$299K	Hold	249,123	–	–	﹤0.01%	113
2022 Q2	$296K	Hold	249,123	–	–	﹤0.01%	113
2022 Q1	$538K	Hold	249,123	–	–	﹤0.01%	114
2021 Q4	$371K	Hold	249,123	–	–	﹤0.01%	121
2021 Q3	$727K	Hold	249,123	–	–	﹤0.01%	121
2021 Q2	$822K	Hold	249,123	–	–	﹤0.01%	117
2021 Q1	$937K	Hold	249,123	–	–	﹤0.01%	119
2020 Q4	$879K	Hold	249,123	–	–	﹤0.01%	120
2020 Q3	$1.64M	Hold	249,123	–	–	0.01%	105
2020 Q2	$1.85M	Hold	249,123	–	–	0.01%	105
2020 Q1	$1.17M	Sell	249,123 -2,428,695	-91%	-$11.4M	0.01%	99
2019 Q4	$3.45M	Hold	2,677,818	–	–	0.02%	78
2019 Q3	$2.81M	Hold	2,677,818	–	–	0.02%	81
2019 Q2	$4.55M	Hold	2,677,818	–	–	0.03%	65
2019 Q1	$9.02M	Hold	2,677,818	–	–	0.06%	50
2018 Q4	$7.82M	Hold	2,677,818	–	–	0.06%	50
2018 Q3	$16.5M	Sell	2,677,818 -1,415,629	-35%	-$8.72M	0.11%	45
2018 Q2	$30.2M	Sell	4,093,447 -58,131	-1%	-$429K	0.23%	34
2018 Q1	$27.2M	Sell	4,151,578 -880,735	-18%	-$5.78M	0.23%	35
2017 Q4	$42.3M	Hold	5,032,313	–	–	0.37%	27
2017 Q3	$58.1M	Hold	5,032,313	–	–	0.47%	19
2017 Q2	$58.8M	Hold	5,032,313	–	–	0.51%	16
2017 Q1	$62.1M	Buy	5,032,313 +166,666	+3%	+$2.06M	0.51%	18
2016 Q4	$66.3M	Hold	4,865,647	–	–	0.65%	16
2016 Q3	$96.8M	Hold	4,865,647	–	–	0.88%	13
2016 Q2	$63.1M	Hold	4,865,647	–	–	0.66%	17
2016 Q1	$45.5M	Hold	4,865,647	–	–	0.48%	25
2015 Q4	$98.6M	Buy	4,865,647 +675,053	+16%	+$13.7M	0.82%	18
2015 Q3	$60.9M	Hold	4,190,594	–	–	0.56%	21
2015 Q2	$89.1M	Hold	4,190,594	–	–	0.78%	17
2015 Q1	$97.1M	Sell	4,190,594 -93,138	-2%	-$2.16M	0.81%	17
2014 Q4	$98.7M	Buy	+4,283,732	New	+$98.7M	1.01%	16